It has previously been shown that both TGFβ and mesenchymal tumor features contribute to immune evasion through upregulation of inhibitory signals that contribute to immune exhaustion, such as PD-L1, stimulation of immune suppressive factors, and inhibition of antigen presentation [25,26]. This evidence concerns the gene TGFB1 and neoplasm.